
|Articles|April 16, 2007
Latebreakers: Combo diabetes drug gets FDA nod
The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
American Pharmacists Month: Students Seeking Both Common, Non-Traditional Pharmacy Careers
2
Pharmacists Improve Diabetes Outcomes Through Continuous Glucose Monitoring Services
3
Leading Cause of Meningitis Shifts from S. Pneumoniae to K. Pneumoniae
4
Vaccine Messaging for Teens Should Tailor to Personal Perspectives
5